Hettie Stroebel Email & Phone Number

Philadelphia, Us

Bringing innovation to patients is no small task, a journey with many challenges, at a hefty price tag.Only 1 out of 10 drugs complete the journey from phase 1 development to regulatory approval. Worse even is that only 1 out of 10 approved drugs achieve launch excellence.Therefore, Life Science companies need to:BEGIN WITH THE END IN MIND.Enabling your organization to develop a product with a compelling and meaningful value proposition to achieve launch excellence and deliver health outcomes for patients.LAUNCH EXCELLENCE PARTNERS a boutique professional services firm and a trusted partner to life sciences companies. We empower teams to develop a product with a compelling and meaningful value proposition, enable organizational alignment and readiness, and achieve effective and efficient external stakeholder engagement and impact, from pre-IND to launch to improve lives of patients.OUR SOLUTIONS are centered around these strategic pillars:A product with a compelling and meaningful value proposition • Target Product Profile Development• Competitive Landscape Assessments• Scientific Platform DevelopmentOrganizational alignment and readiness• Portfolio analytics and prioritization • Forecasts and commercial assessmentsEffective and efficient external stakeholder engagement and impact • Launch Strategy & Planning• Launch Readiness AssessmentsWhy Choose Us• We walked the journey from discovery to post launch bringing innovation to patients.• We have strong business acumen and operating experience to provide unparalleled support.• We have first-hand deep and broad experience to future proof success.• We connect the dots to bridge silos integrating deliverables.• We are a nimble and lean company that bring just the right people to each solution.• We constantly deliver for clients and all new client relationships, start as referrals.We invite Life Science companies to connect with us to learn how we can add value to your Company.

Bethesda, Md, Us

The TABA supplement is essentially a mechanism to help you cover commercialization and business costs that otherwise could not be included in your SBIR/STTR proposal. TABA stands for “Technical and Business Assistance”, and was authorized in 2019 as part of the SBIR/STTR programs. Specifically, TABA supplemental funding enables the awardee business to secure the services of one or more third-party service providers, to assist with one or more of the following commercialization activities:• Identification and development of customers for the SB-funded technology• Advice on financing strategy and fundraising from the private sector• Establishing strategic partnerships with relevant stakeholders• Evaluation and protection of intellectual property• Establishment and evaluation of regulatory and reimbursement strategy• Other activities to accelerate or strengthen the commercialization case for the underlying technology

Philadelphia, Pennsylvania, Us

The Boot Camp will include deep-dive seminars and curated one-on-one meetings with experts on the following topics: Doing business in the U.S. / Localization of your product and service / Legal and visa issues (corporation vs. LLC, JV, visa options) / IP exploration / Funding sources, structures, introduction to local funding ecosystem Accounting/tax/valuation Regulatory and compliance Industry night Pitch to investors HR practices Leveraging conferences for maximum impact

Philadelphia, Pa, Us

University of the Sciences has prepared students to be leaders and practitioners in the healthcare and science fields for nearly 200 years. Key to its distinctive education is a tradition of hands-on research and experiential learning that is evident in every graduate who has walked its campus. Since its founding in 1821 as Philadelphia College of Pharmacy, the first college of pharmacy in North America, USciences has grown to more than 30 degree-granting programs from bachelor’s through doctoral degrees in the health sciences, bench sciences, and healthcare business and policy fields. USciences students are proven everywhere they go.https://www.usciences.edu/

Led development of global branding and marketing strategy from Phase 2 until after launch in US, Japan, Europe, and Asia Pacific. Led development of global commercial strategy focusing on market access, pricing, outcomes/real world evidence, scientific leader advocacy.Executed a new hybrid Go to Market model for the product in the hospital.Worked closely with 15 key markets to implement the key strategic imperatives and sharing best practices.Executed a targeted hospital business plan with the core markets to deliver a significant update and sales performance of the new product.Implemented the first in Merck virtual reality patient education program for country sales organization.

Ensured strong alignment of priorities across the different product development strategic teams of clinical development, access/reimbursement, manufacturing and regulatory to optimize go to market model and across multiple functional and operational stakeholders in Head-Quarters, Regional and Country Level.Delivered commercial input on products in the discovery phase to determine go/no-go decision to start phase 1 development.Engaged and collaborated with subject matter experts across the segments to define the strategy and identify the strategic priorities to support our strategy to drive growth, leadership, and ultimately to transform Acute Care Hospital patient care.Led the commercial assessment and development of business cases into all external collaborative licensing and business development initiatives at global and regional level. Provided strategic oversight and ensured coordination and monitoring of the development and marketing of the Licensed Product with strategic business partner

Rahway, New Jersey, Us

Rahway, New Jersey, Us

Rahway, New Jersey, Us

Rahway, New Jersey, Us

Rahway, New Jersey, Us

Rahway, New Jersey, Us

Rahway, New Jersey, Us